This is a Small Business Research Initiative (SBRI) competition funded by Innovate UK. Organisations can apply for a share of £6 million, inclusive of VAT, to develop or repurpose platform technologies.
The aim of the competition is to accelerate innovations in dementia biomarker detection to transform clinical trials and precision therapies.
This will be achieved by the development of or repurposing of technologies that will enable the robust detection of emerging dementia clinical biomarkers. The application of innovations in wet biomarkers, data, and tools and services, will feed into and support the aims of the UK government’s Dame Barbara Windsor dementia mission.
This is a single-phase competition.
In applying to this competition you are entering into a competitive process.
Any adoption and implementation of a solution from this competition would be subject to a separate, possibly competitive, procurement exercise. This competition does not cover the purchase of any solution.
Your project must:
- improve the sensitive detection of neurodegeneration, inflammation or vascular biomarkers associated with dementia
- advance the development of a novel biomarker platform or repurposed technology towards dementia indications
- describe how the technological solution would be implemented, including consideration of dementia patients, their carers and infrastructure and healthcare requirements
- consider diversity of patients to provide an accessible, equitable solution
- describe a credible and practical route to market, including manufacturing, health economic and regulatory considerations
- have a dedicated project manager
This competition closes on Monday 4 September 2023 at 11:00am.
For full details, please visit this page.
